Cleroindicin F exhibits significant antimicrobial activity, particularly against Gram-positive bacteria. It has been studied for its potential use in developing new antibiotic agents, especially in cases involving drug-resistant strains. Its unique structure allows it to interfere with bacterial cell wall synthesis, making it a candidate for pharmaceutical research in anti-infective therapies. Additionally, it shows moderate antifungal properties, suggesting possible applications in treating fungal infections. Research is ongoing to evaluate its efficacy and safety for clinical use.